Avantor Inc (AVTR)
20.78
+0.42
(+2.09%)
USD |
NYSE |
Nov 22, 16:00
20.78
0.00 (0.00%)
After-Hours: 16:47
Avantor Total Liabilities (Quarterly): 7.287B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 7.287B |
June 30, 2024 | 7.258B |
March 31, 2024 | 7.427B |
December 31, 2023 | 7.720B |
September 30, 2023 | 7.699B |
June 30, 2023 | 8.052B |
March 31, 2023 | 8.401B |
December 31, 2022 | 8.609B |
September 30, 2022 | 8.522B |
June 30, 2022 | 8.961B |
March 31, 2022 | 9.478B |
December 31, 2021 | 9.700B |
Date | Value |
---|---|
September 30, 2021 | 8.094B |
June 30, 2021 | 8.264B |
March 31, 2021 | 6.933B |
December 31, 2020 | 7.232B |
September 30, 2020 | 7.386B |
June 30, 2020 | 7.326B |
March 31, 2020 | 7.346B |
December 31, 2019 | 7.311B |
September 30, 2019 | 7.408B |
June 30, 2019 | 7.607B |
March 31, 2019 | 13.15B |
December 31, 2018 | 12.96B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.933B
Minimum
Mar 2021
9.700B
Maximum
Dec 2021
7.950B
Average
7.709B
Median
Total Liabilities (Quarterly) Benchmarks
Bruker Corp | 4.270B |
Azenta Inc | 331.07M |
Harvard Bioscience Inc | 65.92M |
Bionano Genomics Inc | 38.49M |
Akoya Biosciences Inc | 116.34M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 12.84B |
Shareholders Equity (Quarterly) | 5.553B |
Debt to Equity Ratio | 0.8862 |
Current Ratio | 1.537 |
Net Debt Paydown Yield | 1.09% |